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Clear associations with concomitant SACT, pre-treatment 
symptoms and toxicity were seen. DA was higher than DP 
to all OARs. Differences were small in most patients. 
Despite this, a trend for marginally stronger univariate 
associations between DA parameters, compared to DP, and 
toxicity was seen. Results should be interpreted with 
caution due to multiple testing, and comparison with 
multivariate models is required as a next step. 
Nonetheless, this data is the first to compare relationships 
between both DP & DA and toxicity in HNC, and to suggest 
stronger links with the latter.   
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Purpose or Objective 
Intensity-modulated proton therapy (IMPT) offers 
excellent dose conformity and reduces the integral dose 
in the OAR compared to conventional radiotherapy. During 
the treatment, density changes may alter planned proton 
ranges in the patient and compromise the accuracy of the 
plan. To take into account this effect, isovolume dose 
restoration (iDR) uses isodose contours generated from the 
initial dose distribution and their associated weighted 
objectives (maximum and minimum) to reoptimize the 
plan and reproduce the initial dose in repeated CTs. The 
objective of this work was to test the performance of iDR 
in lung cancer patients. 
Material and Methods 
The provided database included planned and two repeated 
4D-CTs (every two weeks) for fourteen patients. Twelve of 
them present lymph nodes in addition to the primary 
tumour. iDR was performed in the first series of repeated 
4D-CTs. The prescribed dose (Dp) to target was 66 Gy (33 
fractions of 2 Gy). Robust optimization was used for the 
targets, with setup errors of 5mm, range errors of 3%, and 
three phases of the respiratory cycle (end-exhale, end-
inhale, and midV). Plans were optimized based on CTV 
coverage criteria (worst-case D95%>95%Dp and 
D5%<105%Dp) in RayStation (RaySearch Laboratories, 
Sweden). For the evaluation of the results, two different 
metrics were calculated: 1) D95% and D5% dose values for 
the CTV in the nominal case; 2) dose differences between 
restored/distorted and initial dose distributions reported 
by DE(vol=2%) values in four different volumes 
(prescribed, high, medium and low dose regions). 
DE(vol=2%) represents the absolute dose errors 
(evaluation—initial dose) in at most 2% of the analysed 
region. 
Results 
The evaluation of initial plans on repeated CTs showed 
large dose distortions, which were substantially reduced 
after restoration. No target underdosage was observed 
after restoration, whereas for 28% (4/14) of the patients, 
the CTV coverage criteria were not accomplished before 
restoration. In limit cases (21% or 3/14 patients), where 
D95%/D5% levels were reached (only ± 1Gy), iDR improved 
considerably the DVH metrics (see Table 1). In the analysis 
of local dose differences, median DE(vol=2%) decreased 






Restoring clinically-approved dose distribution on 
repeated CTs does not require new ROI segmentation and 
is compatible with an online adaptive workflow. With iDR, 
we are able to accurately reproduce the initial dose, 
despite density changes, maintaining stable the DVH-
based parameters (see Figure.1). Hot spots and 
underdosage in the CTV can be corrected by implementing 
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Purpose or Objective 
Intensity-modulated proton therapy (IMPT) offers 
excellent dose conformity and reduces the integral dose 
in the OAR compared to conventional radiotherapy. During 
the treatment, density changes may alter planned proton 
ranges in the patient and compromise the accuracy of the 
plan. To take into account this effect, isovolume dose 
restoration (iDR) uses isodose contours generated from the 
initial dose distribution and their associated weighted 
objectives (maximum and minimum) to reoptimize the 
plan and reproduce the initial dose in repeated CTs. The 
objective of this work was to test the performance of iDR 
in lung cancer patients. 
Material and Methods 
The provided database included planned and two repeated 
4D-CTs (every two weeks) for fourteen patients. Twelve of 
them present lymph nodes in addition to the primary 
tumour. iDR was performed in the first series of repeated 
4D-CTs. The prescribed dose (Dp) to target was 66 Gy (33 
fractions of 2 Gy). Robust optimization was used for the 
targets, with setup errors of 5mm, range errors of 3%, and 
three phases of the respiratory cycle (end-exhale, end-
inhale, and midV). Plans were optimized based on CTV 
coverage criteria (worst-case D95%>95%Dp and 
D5%<105%Dp) in RayStation (RaySearch Laboratories, 
Sweden). For the evaluation of the results, two different 
metrics were calculated: 1) D95% and D5% dose values for 
the CTV in the nominal case; 2) dose differences between 
restored/distorted and initial dose distributions reported 
by DE(vol=2%) values in four different volumes 
(prescribed, high, medium and low dose regions). 
DE(vol=2%) represents the absolute dose errors 
(evaluation—initial dose) in at most 2% of the analysed 
region. 
Results 
The evaluation of initial plans on repeated CTs showed 
large dose distortions, which were substantially reduced 
after restoration. No target underdosage was observed 
after restoration, whereas for 28% (4/14) of the patients, 
the CTV coverage criteria were not accomplished before 
restoration. In limit cases (21% or 3/14 patients), where 
D95%/D5% levels were reached (only ± 1Gy), iDR improved 
considerably the DVH metrics (see Table 1). In the analysis 
of local dose differences, median DE(vol=2%) decreased 
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Purpose or Objective 
During radiotherapy treatment (RT) of abdominal 
pediatric tumors, inter-fraction anatomical changes such 
as patient’s diameter variations due to weight loss/gain 
and different gastrointestinal gas volumes might occur. 
The goal of this study was to investigate the dosimetric 
impact of daily anatomical changes based on cone-beam 
computed tomography (CBCT) information in robust 
optimized photon and proton RT dose distributions. 
Material and Methods 
Volumetric modulated arc therapy (VMAT) and pencil 
beam scanning proton therapy (PBS) dose distributions 
were calculated using the original planning-CT scan for 20 
pediatric patients (average 3, range 1-8 years) treated for 
neuroblastoma (n=11) and Wilms’ tumor (n=9). VMAT plans 
were based on a 6 MV full-arc while PBS plans on 2-3 
posterior-oblique fields with prescribed doses (PD) ranging 
between 14.4-36 Gy. Treatment plans were robust 
optimized on the patient-specific internal target volume 
(ITV) using a uniform 5 mm set-up uncertainty. Moreover, 
for the PBS plans a 3% proton range uncertainty was 
accounted for. The plan robustness  was evaluated using 
multiple dose distributions associated with various error 
scenarios: set-up (with the magnitude of 5 mm in 26 
directions per VMAT and PBS plans) and range errors (±3% 
density scaling, resulting in 52 scenarios per PBS plan). 
Plans were accepted if the V95% of the ITV > 98% in the 
voxel-wise minimum evaluation dose. Fractional dose re-
calculations were performed using clinical CBCT images. 
For the estimation of Hounsfield units (HUs) from the daily 
CBCT data, the gas volumes on the planning-CT were filled 
with a water equivalent density and the planning-CT was 
deformably registered to each CBCT. Gas volumes were 
delineated on the CBCTs and copied rigidly to the 
deformed CTs (dCTs). Fractional doses were re-calculated 
on the dCTs and accumulated rigidly. To compare planned 
and accumulated doses, dose-volume histogram (DVH) 
parameters were calculated for the clinical ITV and organs 
at risk (OARs). 
Results 
For both techniques, the ITV coverage was fulfilled for the 
original planned dose distributions. For the ITV, mean 
differences between planned and accumulated doses 
ranged between [-0.1% - 0.8%] and [-0.1% - 0.1%] for the 
VMAT and PBS plans (Table 1), respectively. On the 
accumulated doses, the ITV coverage was not reached 
(V95% < 99%) for 2 patients, for the VMAT plans (Figure 1). 
For the OARs, mean differences between planned and 
accumulated doses ranged between [-0.4% - 0.2%] and [-









In this study, the need of performing re-planning during 
RT was evaluated for children treated for 
abdominal  tumors. RT using PBS with posterior-oblique 
irradiation fields proved to be highly robust against 
anatomical inter-fraction changes. In photon therapy 
using a VMAT delivery, daily anatomical changes proved to 
affect the target coverage to a higher extent when 
compared to PBS. 
 
PO-0987  Rotational setup errors in breast cancer 
radiotherapy: the effect on treatment margins. 
J. Seppala1, K. Vuolukka1, T. Viren1, J. Heikkilä1, J. 
Honkanen1, A. Pandey2, A. Al-Gburi2, M. Shah2, S. Sefa2, 
T. Koivumäki3 
1Kuopio University Hospital, Center of Oncology, Kuopio, 
Finland ; 2University of Eastern Finland, Department of 
Applied Physics, Kuopio, Finland ; 3Central Finland 
Central Hospital, Department of Medical Physics, 
Jyväskylä, Finland  
 
Purpose or Objective 
Rotational errors might have a significant effect on 
radiotherapy (RT) target coverage if not considered in PTV 
margins. In this work, we investigated the residual 
rotational errors in breast cancer RT. 
Material and Methods 
Daily low dose CBCT setup images of 93 breast cancer 
patients treated with RT were retrospectively investigated 
for rotational errors in patient setup. Patients were 
imaged with CT in supine position arms above the head on 
a breast board (C-Qual™ Breastboard, Civco, USA). 20 of 
the patients were imaged in deep inspiration breath hold 
(DIBH). With 50 patients, the treatment area included the 
whole breast and with 43 patients, the treatment area 
included also the axillary lymph nodes. A 3D image co-
registration was conducted between 1731 CBCT images 
and the respective planning CT images (Mosaiq system 
v2.62, Elekta AB) and image translation and rotations in 
coronal (COR), sagittal (SAG) and transversal (TRA) planes 
were recorded (Fig 1). Pearson correlation coefficient was 
used to determine the relation between the magnitude of 
rotational error and body mass index (BMI), age, side of a 
treatment, use of DIBH, chemotherapy, time between 
surgery and RT and the number of fractions (either 15 or 
25). 
 
